BOSULIF (BOSUTINIB MONOHYDRATE) — FDA Approval NDA217729 (PF PRISM CV)
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA Approval NDA217729 (PF PRISM CV) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BOSULIF; Active ingredients: BOSUTINIB MONOHYDRATE; Application number: NDA217729.
| Brand name | BOSULIF |
|---|---|
| Active ingredients | BOSUTINIB MONOHYDRATE |
| Application number | NDA217729 |
| Sponsor | PF PRISM CV |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20230926 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →